Irinotecan hydrochloride liposomal (Sichuan Kelun Pharma)
盐酸伊立替康脂质体 (四川科伦药物)
Report date: 2026/01/29 20:00:06
Base Information
Drug NameIrinotecan hydrochloride liposomal (Sichuan Kelun Pharma)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesSichuan Kelun Pharmacy Institute Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesSichuan Kelun Pharmacy Institute Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A